ReviewSub-cellular biochemistry2025
Advancements in Chronic Wasting Disease (CWD) Prion Detection: Moving Beyond the Gold Standards.
Review in Sub-cellular biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chronic wasting disease (CWD) is perhaps the most problematic prion disease at present, considering its rapid spread in North America, its presence in both captive and wild animals, and its unknown zoonotic potential. Although several strategies have been attempted to contain the spread of CWD, their success appears to be limited. One of the main problems associated with the management of this disease lies in its diagnosis. At present, CWD diagnosis is evaluated using post-mortem tissues using techniques of insufficient analytical sensitivity. As a consequence, these techniques do not allow for the identification of infected animals using biological samples that could be collected from live subjects. Along this line, further development of prion amplification methods may fill this much-needed gap. This chapter summarizes the current methods used to diagnose CWD in regulatory and laboratory settings, and provides perspectives on how new technologies may help facilitate the identification of diseased animals.
Indexed as
Identifiers
41004051What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.